Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

February 28, 2019

Study Completion Date

July 27, 2020

Conditions
Partial Onset Seizures
Interventions
DRUG

E2007

Oral tablet

Trial Locations (38)

Unknown

Eisai Trial Site #18, Aichi

Eisai Trial Site #19, Aichi

Eisai Trial Site #11, Fukuoka

Eisai Trial Site #29, Fukuoka

Eisai Trial Site #4, Hiroshima

Eisai Trial Site #16, Hokkaido

Eisai Trial Site #8, Hokkaido

Eisai Trial Site #14, Hyōgo

Eisai Trial Site #6, Hyōgo

Eisai Trial Site #7, Kagoshima

Eisai Trial Site #9, Kanagawa

Eisai Trial Site #10, Kyoto

Eisai Trial Site #30, Miyagi

Eisai Trial Site #25, Nagasaki

Eisai Trial Site #27, Nagasaki

Eisai Trial Site #15, Nara

Eisai Trial Site #12, Niigata

Eisai Trial Site #21, Osaka

Eisai Trial Site #24, Osaka

Eisai Trial Site #26, Osaka

Eisai Trial Site #3, Saitama

Eisai Trial Site #5, Saitama

Eisai Trial Site #1, Shizuoka

Eisai Trial Site #22, Tochigi

Eisai Trial Site #28, Tokushima

Eisai Trial Site #20, Tokyo

Eisai Trial Site #23, Tokyo

Eisai Trial Site #31, Tokyo

Eisai Trial Site #13, Yamagata

Eisai Trial Site #17, Yamaguchi

Eisai Trial Site #32, Yamaguchi

Eisai Trial Site #38, Gyeonggi-do

Eisai Trial Site #36, Incheon

Eisai Trial Site # 2, Seoul

Eisai Trial Site #33, Seoul

Eisai Trial Site #34, Seoul

Eisai Trial Site #35, Seoul

Eisai Trial Site #37, Seoul

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT03201900 - Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study) | Biotech Hunter | Biotech Hunter